Key statistics
On Friday, Tandem Diabetes Care Inc (TD5A:DEU) closed at 39.75, -18.83% below its 52-week high of 48.97, set on May 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 39.50 |
---|---|
High | 39.75 |
Low | 39.50 |
Bid | 39.60 |
Offer | 40.41 |
Previous close | 39.68 |
Average volume | 28.80 |
---|---|
Shares outstanding | 65.46m |
Free float | 64.97m |
P/E (TTM) | -- |
Market cap | 2.92bn USD |
EPS (TTM) | -2.09 USD |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Press releases
- Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union
- Tandem Diabetes Care Announces Upcoming Conference Participation
- Tandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide Recall
- Tandem Diabetes Care Provides Update on March 2024 Nationwide Recall of t:connect Mobile App for iOS Devices
- Tandem Diabetes Care Announces Second Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance
- Tandem Diabetes Care Announces Upcoming Conference Presentation
- Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada
- Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024
More ▼